Characteristics | Training (n = 728) | Validation-1 (n = 262) | Validation-2 (n = 404) | Combined cohorts (n = 1394) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Low (n = 365) | High (n = 363) | P | Low (n = 123) | High (n = 139) | P | Low (n = 157) | High (n = 247) | P | Low (n = 645) | High (n = 749) | P | |
Age (years)* | 53.3±12.1 | 52.8±11.3 | 0.622 | 53.5±13.3 | 55.4±13.5 | 0.241 | 54.4±11.9 | 56.8±11.1 | 0.039 | 53.6±12.3 | 54.6±11.8 | 0.105 |
Sex | Â | Â | 0.050 | Â | Â | 0.050 | Â | Â | 0.778 | Â | Â | 0.596 |
 Male | 302 (82.7) | 319 (87.9) |  | 107 (87.0) | 108 (77.7) |  | 140 (89.2) | 218 (88.3) |  | 549 (85.1) | 645 (86.1) |  |
 Female | 63 (17.3) | 44 (12.1) |  | 16 (13.0) | 31 (22.3) |  | 17 (10.8) | 29 (11.7) |  | 96 (14.9) | 104 (13.9) |  |
BMI (kg/m2) # | 21.9 (19.8–24.3) | 22.9 (20.8–25.5) | < 0.001 | 22.5 (20.2–25.8) | 22.9 (19.9–25.8) | 0.976 | 22.0 (19.6–24.7) | 22.7 (20.8–25.5) | 0.010 | 21.0 (18.0-23.7) | 21.9 (18.6–24.8) | < 0.001 |
BCLC staging (n, %) |  |  | < 0.001 |  |  | 0.776 |  |  | - |  |  | < 0.001 |
 0 | 12 (3.3) | 39 (10.7) |  | 10 (8.1) | 10 (7.2) |  | 0 | 0 |  | 22 (3.4) | 49 (6.5) |  |
 A | 353 (96.7) | 324 (89.3) |  | 113 (91.9) | 129 (92.8) |  | 0 | 0 |  | 466 (72.2) | 453 (60.5) |  |
 B | - | - |  | - | - |  | 157 | 247 |  | 157 (24.3) | 247 (33.0) |  |
Etiologies of hepatitis (n, %) | Â | Â | 0.034 | Â | Â | 0.646 | Â | Â | 0.032 | Â | Â | 0.006 |
 None | 48 (13.2) | 29 (8.0) |  | 34 (27.6) | 33 (23.7) |  | 29 (18.5) | 25 (10.1) |  | 111 (17.2) | 87 (11.6) |  |
 HBV | 266 (72.9) | 292 (80.4) |  | 85 (69.1) | 103 (74.1) |  | 121 (77.1) | 203 (82.2) |  | 472 (73.2) | 598 (79.8) |  |
 Others | 51 (14.0) | 42 (11.6) |  | 4 (3.3) | 3 (2.2) |  | 7 (4.5) | 19 (7.7) |  | 62 (9.6) | 64 (8.5) |  |
Liver cirrhosis (n, %) |  |  | < 0.001 |  |  | < 0.001 |  |  | < 0.001 |  |  | < 0.001 |
 Absence | 200 (54.8) | 154 (42.4) |  | 38 (30.9) | 88 (63.3) |  | 90 (57.3) | 63 (25.5) |  | 328 (50.9) | 305 (40.7) |  |
 Presence | 165 (45.2) | 209 (57.6) |  | 85 (69.1) | 51 (36.7) |  | 67 (42.7) | 184 (74.5) |  | 317 (49.1) | 444 (59.3) |  |
Tumor size (n, %) |  |  | < 0.001 |  |  | 0.909 |  |  | < 0.001 |  |  | < 0.001 |
 ≤ 50 mm | 108 (29.6) | 243 (66.9) |  | 69 (56.1) | 77 (55.4) |  | 37 (23.6) | 174 (70.4) |  | 214 (33.2) | 494 (66.0) |  |
 > 50 mm | 257 (70.4) | 120 (33.1) |  | 54 (43.9) | 62 (44.6) |  | 120 (76.4) | 73 (29.6) |  | 431 (66.8) | 255 (34.0) |  |
Number of tumors (n, %) | Â | Â | 0.893 | Â | Â | 0.955 | Â | Â | - | Â | Â | 0.005 |
 Solitary | 310 (84.9) | 307 (84.6) |  | 105 (85.4) | 119 (85.6) |  | 0 | 0 |  | 415 (64.3) | 426 (56.9) |  |
 Multinodular | 55 (15.1) | 56 (15.4) |  | 18 (14.6) | 20 (14.4) |  | 157 | 247 |  | 230 (35.7) | 323 (43.1) |  |
Up-to-seven criteria (n, %) |  |  | < 0.001 |  |  | 0.632 |  |  | < 0.001 |  |  | < 0.001 |
 Within | 142 (38.9) | 276 (76.0) |  | 77 (62.6) | 83 (59.7) |  | 33 (21.0) | 163 (66.0) |  | 252 (39.1) | 522 (69.7) |  |
 Beyond | 223 (61.1) | 87 (24.0) |  | 46 (37.4) | 56 (40.3) |  | 124 (79.0) | 84 (34.0) |  | 393 (60.9) | 227 (30.3) |  |
Creatine (umol/L) # | 70.2 (59.6–79.6) | 72.2 (63.0-83.5) | 0.006 | 66.0 (59.0-79.7) | 66.0 (55.4–75.8) | 0.110 | 71.8 (61.9–79.3) | 72.7 (62.0-81.9) | 0.582 | 70.1 (60.0-79.3) | 71.2 (61.0–81.0) | 0.098 |
Total bilirubin (umol/L) # | 13.0 (9.3–17.6) | 14.6 (11.0-19.2) | < 0.001 | 14.4 (10.5–20.2) | 11.6 (8.7–17.1) | 0.004 | 14.7 (11.4–21.0) | 16.5 (12.6–24.2) | 0.045 | 13.7 (10.1–19.1) | 14.8 (11.0–20.0) | 0.007 |
Albumin (g/L) # | 38.6 (35.6–41.4) | 38.7 (36.1–41.1) | 0.662 | 41.5 (37.5–44.6) | 40.9 (37.1–43.5) | 0.126 | 38.3 (35.2–41.2) | 37.5 (33.2–41.0) | 0.148 | 39.0 (35.7–42.1) | 38.7 (35.6–41.6) | 0.197 |
ALBI grade (n, %) | Â | Â | 0.698 | Â | Â | 0.845 | Â | Â | 0.698 | Â | Â | 0.508 |
 I | 156 (42.7) | 150 (41.3) |  | 80 (65.0) | 92 (66.2) |  | 57 (36.3) | 85 (34.4) |  | 293 (45.4) | 327 (43.7) |  |
 II | 209 (57.3) | 213 (58.7) |  | 43 (35.0) | 47 (33.8) |  | 100 (63.7) | 162 (65.6) |  | 352 (54.6) | 422 (56.3) |  |
Neutrophil (× 109) # | 4.33 (3.40–5.35) | 2.64 (2.04–3.38) | < 0.001 | 3.51 (2.26–4.55) | 3.05 (2.18–3.94) | 0.103 | 4.36 (3.30–5.53) | 2.29 (1.71–3.01) | < 0.001 | 4.20 (3.18–5.24) | 2.60 (1.90–3.36) | < 0.001 |
Lymphocyte (× 109) # | 1.32 (1.03–1.63) | 1.41 (1.06–1.84) | 0.019 | 1.25 (0.97–1.77) | 1.37 (1.05–1.86) | 0.161 | 1.21 (0.90–1.61) | 1.27 (0.92–1.70) | 0.575 | 1.30 (1.01–1.66) | 1.36 (1.02–1.80) | 0.026 |
Platelet (× 109) # | 210.0 (163.0-258.5) | 122.0 (86.0-159.0) | < 0.001 | 157.0 (101.0-215.0) | 147.0 (101.0-209.0) | 0.924 | 199.0 (154.5-250.5) | 99.0 (68.0-136.0) | < 0.001 | 196.5 (148.9-251.1) | 118.2 (81.0-159.1) | < 0.001 |
Monocyte (× 109) # | 0.38 (0.27–0.51) | 0.28 (0.21–0.37) | < 0.001 | 0.43 (0.34–0.57) | 0.46 (0.34–0.62) | 0.294 | 0.48 (0.36–0.62) | 0.33 (0.23–0.46) | < 0.001 | 0.41 (0.29–0.54) | 0.32 (0.23–0.44) | < 0.001 |
SII # | 623.6 (469.2-915.1) | 236.9 (154.8-307.6) | < 0.001 | 592.3 (446.8-840.7) | 203.3 (146.8-284.8) | < 0.001 | 659.9 (479.7-1029.5) | 190.7 (120.7-252.7) | < 0.001 | 628.1 (466.1-931.5) | 209.6 (141.0-289.0) | < 0.001 |
SMA (cm2) # | 107.9 (88.5–124.0) | 119.9 (104.3-137.2) | < 0.001 | 109.3 (82.9-124.8) | 118.1 (102.1-137.6) | < 0.001 | 109.1 (85.8-125.7) | 118.6 (102.3-136.6) | < 0.001 | 108.3 (86.2-124.7) | 119.2 (103.8-136.9) | < 0.001 |
SMI (cm2/m2) # | 38.9 (32.7–44.2) | 43.6 (38.0-49.2) | < 0.001 | 39.2 (30.6–45.1) | 43.6 (37.4–49.7) | < 0.001 | 40.4 (32.5–44.9) | 43.2 (37.3–49.0) | < 0.001 | 39.1 (32.4–44.4) | 43.5 (37.5–49.1) | < 0.001 |
AFP level (n, %) |  |  | 0.011 |  |  | 0.121 |  |  | < 0.001 |  |  | < 0.001 |
≤ 200ng/mL | 207 (56.7) | 239 (65.8) |  | 69 (56.1) | 91 (65.5) |  | 72 (45.9) | 162 (65.6) |  | 348 (54.0) | 492 (65.7) |  |
> 200ng/mL | 158 (43.3) | 124 (34.2) |  | 54 (43.9) | 48 (34.5) |  | 85 (54.1) | 85 (34.4) |  | 297 (46.0) | 257 (34.3) |  |